世界のウェアラブルドラッグデリバリーシステム市場インサイト及び予測(電子ドラッグデリバリーデバイス、メカニカルドラッグデリバリーデバイス)

◆英語タイトル:Global Wearable Drug Delivery Systems Market Insights, Forecast to 2028

QYResearchが発行した調査報告書(QY22JLX10260)◆商品コード:QY22JLX10260
◆発行会社(リサーチ会社):QYResearch
◆発行日:2022年7月(※2025年版があります。お問い合わせください。)
◆ページ数:116
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥744,800見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,117,200見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,489,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、ウェアラブルドラッグデリバリーシステムのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にウェアラブルドラッグデリバリーシステムの世界市場のxxx%を占める「電子ドラッグデリバリーデバイス」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
ウェアラブルドラッグデリバリーシステムの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのウェアラブルドラッグデリバリーシステム市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

ウェアラブルドラッグデリバリーシステムのグローバル主要企業には、Gerresheimer、Owen Mumford、Sonceboz、United Therapeutics、Ypsomed、Elcam Medical、Enable Injections、Unilife Corporation、West Pharma、Eitan Medical、BD Medical、Noble International、Insulet、Amgen、Roche、CeQur、ScPharmaceuticalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

ウェアラブルドラッグデリバリーシステム市場は、種類と用途によって区分されます。世界のウェアラブルドラッグデリバリーシステム市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
電子ドラッグデリバリーデバイス、メカニカルドラッグデリバリーデバイス

【用途別セグメント】
病院、診療所、在宅医療、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- ウェアラブルドラッグデリバリーシステム製品概要
- 種類別市場(電子ドラッグデリバリーデバイス、メカニカルドラッグデリバリーデバイス)
- 用途別市場(病院、診療所、在宅医療、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界のウェアラブルドラッグデリバリーシステム販売量予測2017-2028
- 世界のウェアラブルドラッグデリバリーシステム売上予測2017-2028
- ウェアラブルドラッグデリバリーシステムの地域別販売量
- ウェアラブルドラッグデリバリーシステムの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ウェアラブルドラッグデリバリーシステム販売量
- 主要メーカー別ウェアラブルドラッグデリバリーシステム売上
- 主要メーカー別ウェアラブルドラッグデリバリーシステム価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(電子ドラッグデリバリーデバイス、メカニカルドラッグデリバリーデバイス)
- ウェアラブルドラッグデリバリーシステムの種類別販売量
- ウェアラブルドラッグデリバリーシステムの種類別売上
- ウェアラブルドラッグデリバリーシステムの種類別価格
・用途別市場規模(病院、診療所、在宅医療、その他)
- ウェアラブルドラッグデリバリーシステムの用途別販売量
- ウェアラブルドラッグデリバリーシステムの用途別売上
- ウェアラブルドラッグデリバリーシステムの用途別価格
・北米市場
- 北米のウェアラブルドラッグデリバリーシステム市場規模(種類別、用途別)
- 主要国別のウェアラブルドラッグデリバリーシステム市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのウェアラブルドラッグデリバリーシステム市場規模(種類別、用途別)
- 主要国別のウェアラブルドラッグデリバリーシステム市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のウェアラブルドラッグデリバリーシステム市場規模(種類別、用途別)
- 主要国別のウェアラブルドラッグデリバリーシステム市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のウェアラブルドラッグデリバリーシステム市場規模(種類別、用途別)
- 主要国別のウェアラブルドラッグデリバリーシステム市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのウェアラブルドラッグデリバリーシステム市場規模(種類別、用途別)
- 主要国別のウェアラブルドラッグデリバリーシステム市場規模(トルコ、サウジアラビア)
・企業情報
Gerresheimer、Owen Mumford、Sonceboz、United Therapeutics、Ypsomed、Elcam Medical、Enable Injections、Unilife Corporation、West Pharma、Eitan Medical、BD Medical、Noble International、Insulet、Amgen、Roche、CeQur、ScPharmaceuticals
・産業チェーン及び販売チャネル分析
- ウェアラブルドラッグデリバリーシステムの産業チェーン分析
- ウェアラブルドラッグデリバリーシステムの原材料
- ウェアラブルドラッグデリバリーシステムの生産プロセス
- ウェアラブルドラッグデリバリーシステムの販売及びマーケティング
- ウェアラブルドラッグデリバリーシステムの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ウェアラブルドラッグデリバリーシステムの産業動向
- ウェアラブルドラッグデリバリーシステムのマーケットドライバー
- ウェアラブルドラッグデリバリーシステムの課題
- ウェアラブルドラッグデリバリーシステムの阻害要因
・主な調査結果

Market Analysis and Insights: Global Wearable Drug Delivery Systems Market
Due to the COVID-19 pandemic, the global Wearable Drug Delivery Systems market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Electronical Drug Delivery Devices accounting for % of the Wearable Drug Delivery Systems global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Wearable Drug Delivery Systems market size is valued at US$ million in 2021, while the US and Europe Wearable Drug Delivery Systems are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Wearable Drug Delivery Systems landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Wearable Drug Delivery Systems include Gerresheimer, Owen Mumford, Sonceboz, United Therapeutics, Ypsomed, Elcam Medical, Enable Injections, Unilife Corporation and West Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Wearable Drug Delivery Systems Scope and Segment
Wearable Drug Delivery Systems market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Wearable Drug Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Electronical Drug Delivery Devices
Mechanical Drug Delivery Devices
Segment by Application
Hospital
Clinic
Home Care
Others
By Company
Gerresheimer
Owen Mumford
Sonceboz
United Therapeutics
Ypsomed
Elcam Medical
Enable Injections
Unilife Corporation
West Pharma
Eitan Medical
BD Medical
Noble International
Insulet
Amgen
Roche
CeQur
ScPharmaceuticals
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Wearable Drug Delivery Systems Product Introduction
1.2 Market by Type
1.2.1 Global Wearable Drug Delivery Systems Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Electronical Drug Delivery Devices
1.2.3 Mechanical Drug Delivery Devices
1.3 Market by Application
1.3.1 Global Wearable Drug Delivery Systems Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Wearable Drug Delivery Systems Sales Estimates and Forecasts 2017-2028
2.2 Global Wearable Drug Delivery Systems Revenue Estimates and Forecasts 2017-2028
2.3 Global Wearable Drug Delivery Systems Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Wearable Drug Delivery Systems Sales by Region
2.4.1 Global Wearable Drug Delivery Systems Sales by Region (2017-2022)
2.4.2 Global Sales Wearable Drug Delivery Systems by Region (2023-2028)
2.5 Global Wearable Drug Delivery Systems Revenue by Region
2.5.1 Global Wearable Drug Delivery Systems Revenue by Region (2017-2022)
2.5.2 Global Wearable Drug Delivery Systems Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Wearable Drug Delivery Systems Sales by Manufacturers
3.1.1 Global Top Wearable Drug Delivery Systems Manufacturers by Sales (2017-2022)
3.1.2 Global Wearable Drug Delivery Systems Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Wearable Drug Delivery Systems in 2021
3.2 Global Wearable Drug Delivery Systems Revenue by Manufacturers
3.2.1 Global Wearable Drug Delivery Systems Revenue by Manufacturers (2017-2022)
3.2.2 Global Wearable Drug Delivery Systems Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Wearable Drug Delivery Systems Revenue in 2021
3.3 Global Wearable Drug Delivery Systems Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Wearable Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Wearable Drug Delivery Systems Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Wearable Drug Delivery Systems Sales by Type
4.1.1 Global Wearable Drug Delivery Systems Historical Sales by Type (2017-2022)
4.1.2 Global Wearable Drug Delivery Systems Forecasted Sales by Type (2023-2028)
4.1.3 Global Wearable Drug Delivery Systems Sales Market Share by Type (2017-2028)
4.2 Global Wearable Drug Delivery Systems Revenue by Type
4.2.1 Global Wearable Drug Delivery Systems Historical Revenue by Type (2017-2022)
4.2.2 Global Wearable Drug Delivery Systems Forecasted Revenue by Type (2023-2028)
4.2.3 Global Wearable Drug Delivery Systems Revenue Market Share by Type (2017-2028)
4.3 Global Wearable Drug Delivery Systems Price by Type
4.3.1 Global Wearable Drug Delivery Systems Price by Type (2017-2022)
4.3.2 Global Wearable Drug Delivery Systems Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Wearable Drug Delivery Systems Sales by Application
5.1.1 Global Wearable Drug Delivery Systems Historical Sales by Application (2017-2022)
5.1.2 Global Wearable Drug Delivery Systems Forecasted Sales by Application (2023-2028)
5.1.3 Global Wearable Drug Delivery Systems Sales Market Share by Application (2017-2028)
5.2 Global Wearable Drug Delivery Systems Revenue by Application
5.2.1 Global Wearable Drug Delivery Systems Historical Revenue by Application (2017-2022)
5.2.2 Global Wearable Drug Delivery Systems Forecasted Revenue by Application (2023-2028)
5.2.3 Global Wearable Drug Delivery Systems Revenue Market Share by Application (2017-2028)
5.3 Global Wearable Drug Delivery Systems Price by Application
5.3.1 Global Wearable Drug Delivery Systems Price by Application (2017-2022)
5.3.2 Global Wearable Drug Delivery Systems Price Forecast by Application (2023-2028)
6 North America
6.1 North America Wearable Drug Delivery Systems Market Size by Type
6.1.1 North America Wearable Drug Delivery Systems Sales by Type (2017-2028)
6.1.2 North America Wearable Drug Delivery Systems Revenue by Type (2017-2028)
6.2 North America Wearable Drug Delivery Systems Market Size by Application
6.2.1 North America Wearable Drug Delivery Systems Sales by Application (2017-2028)
6.2.2 North America Wearable Drug Delivery Systems Revenue by Application (2017-2028)
6.3 North America Wearable Drug Delivery Systems Market Size by Country
6.3.1 North America Wearable Drug Delivery Systems Sales by Country (2017-2028)
6.3.2 North America Wearable Drug Delivery Systems Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Wearable Drug Delivery Systems Market Size by Type
7.1.1 Europe Wearable Drug Delivery Systems Sales by Type (2017-2028)
7.1.2 Europe Wearable Drug Delivery Systems Revenue by Type (2017-2028)
7.2 Europe Wearable Drug Delivery Systems Market Size by Application
7.2.1 Europe Wearable Drug Delivery Systems Sales by Application (2017-2028)
7.2.2 Europe Wearable Drug Delivery Systems Revenue by Application (2017-2028)
7.3 Europe Wearable Drug Delivery Systems Market Size by Country
7.3.1 Europe Wearable Drug Delivery Systems Sales by Country (2017-2028)
7.3.2 Europe Wearable Drug Delivery Systems Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Wearable Drug Delivery Systems Market Size by Type
8.1.1 Asia Pacific Wearable Drug Delivery Systems Sales by Type (2017-2028)
8.1.2 Asia Pacific Wearable Drug Delivery Systems Revenue by Type (2017-2028)
8.2 Asia Pacific Wearable Drug Delivery Systems Market Size by Application
8.2.1 Asia Pacific Wearable Drug Delivery Systems Sales by Application (2017-2028)
8.2.2 Asia Pacific Wearable Drug Delivery Systems Revenue by Application (2017-2028)
8.3 Asia Pacific Wearable Drug Delivery Systems Market Size by Region
8.3.1 Asia Pacific Wearable Drug Delivery Systems Sales by Region (2017-2028)
8.3.2 Asia Pacific Wearable Drug Delivery Systems Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Wearable Drug Delivery Systems Market Size by Type
9.1.1 Latin America Wearable Drug Delivery Systems Sales by Type (2017-2028)
9.1.2 Latin America Wearable Drug Delivery Systems Revenue by Type (2017-2028)
9.2 Latin America Wearable Drug Delivery Systems Market Size by Application
9.2.1 Latin America Wearable Drug Delivery Systems Sales by Application (2017-2028)
9.2.2 Latin America Wearable Drug Delivery Systems Revenue by Application (2017-2028)
9.3 Latin America Wearable Drug Delivery Systems Market Size by Country
9.3.1 Latin America Wearable Drug Delivery Systems Sales by Country (2017-2028)
9.3.2 Latin America Wearable Drug Delivery Systems Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Wearable Drug Delivery Systems Market Size by Type
10.1.1 Middle East and Africa Wearable Drug Delivery Systems Sales by Type (2017-2028)
10.1.2 Middle East and Africa Wearable Drug Delivery Systems Revenue by Type (2017-2028)
10.2 Middle East and Africa Wearable Drug Delivery Systems Market Size by Application
10.2.1 Middle East and Africa Wearable Drug Delivery Systems Sales by Application (2017-2028)
10.2.2 Middle East and Africa Wearable Drug Delivery Systems Revenue by Application (2017-2028)
10.3 Middle East and Africa Wearable Drug Delivery Systems Market Size by Country
10.3.1 Middle East and Africa Wearable Drug Delivery Systems Sales by Country (2017-2028)
10.3.2 Middle East and Africa Wearable Drug Delivery Systems Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Gerresheimer
11.1.1 Gerresheimer Corporation Information
11.1.2 Gerresheimer Overview
11.1.3 Gerresheimer Wearable Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Gerresheimer Wearable Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Gerresheimer Recent Developments
11.2 Owen Mumford
11.2.1 Owen Mumford Corporation Information
11.2.2 Owen Mumford Overview
11.2.3 Owen Mumford Wearable Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Owen Mumford Wearable Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Owen Mumford Recent Developments
11.3 Sonceboz
11.3.1 Sonceboz Corporation Information
11.3.2 Sonceboz Overview
11.3.3 Sonceboz Wearable Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sonceboz Wearable Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sonceboz Recent Developments
11.4 United Therapeutics
11.4.1 United Therapeutics Corporation Information
11.4.2 United Therapeutics Overview
11.4.3 United Therapeutics Wearable Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 United Therapeutics Wearable Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 United Therapeutics Recent Developments
11.5 Ypsomed
11.5.1 Ypsomed Corporation Information
11.5.2 Ypsomed Overview
11.5.3 Ypsomed Wearable Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Ypsomed Wearable Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Ypsomed Recent Developments
11.6 Elcam Medical
11.6.1 Elcam Medical Corporation Information
11.6.2 Elcam Medical Overview
11.6.3 Elcam Medical Wearable Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Elcam Medical Wearable Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Elcam Medical Recent Developments
11.7 Enable Injections
11.7.1 Enable Injections Corporation Information
11.7.2 Enable Injections Overview
11.7.3 Enable Injections Wearable Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Enable Injections Wearable Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Enable Injections Recent Developments
11.8 Unilife Corporation
11.8.1 Unilife Corporation Corporation Information
11.8.2 Unilife Corporation Overview
11.8.3 Unilife Corporation Wearable Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Unilife Corporation Wearable Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Unilife Corporation Recent Developments
11.9 West Pharma
11.9.1 West Pharma Corporation Information
11.9.2 West Pharma Overview
11.9.3 West Pharma Wearable Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 West Pharma Wearable Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 West Pharma Recent Developments
11.10 Eitan Medical
11.10.1 Eitan Medical Corporation Information
11.10.2 Eitan Medical Overview
11.10.3 Eitan Medical Wearable Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Eitan Medical Wearable Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Eitan Medical Recent Developments
11.11 BD Medical
11.11.1 BD Medical Corporation Information
11.11.2 BD Medical Overview
11.11.3 BD Medical Wearable Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 BD Medical Wearable Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 BD Medical Recent Developments
11.12 Noble International
11.12.1 Noble International Corporation Information
11.12.2 Noble International Overview
11.12.3 Noble International Wearable Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Noble International Wearable Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Noble International Recent Developments
11.13 Insulet
11.13.1 Insulet Corporation Information
11.13.2 Insulet Overview
11.13.3 Insulet Wearable Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Insulet Wearable Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Insulet Recent Developments
11.14 Amgen
11.14.1 Amgen Corporation Information
11.14.2 Amgen Overview
11.14.3 Amgen Wearable Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Amgen Wearable Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Amgen Recent Developments
11.15 Roche
11.15.1 Roche Corporation Information
11.15.2 Roche Overview
11.15.3 Roche Wearable Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Roche Wearable Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Roche Recent Developments
11.16 CeQur
11.16.1 CeQur Corporation Information
11.16.2 CeQur Overview
11.16.3 CeQur Wearable Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 CeQur Wearable Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 CeQur Recent Developments
11.17 ScPharmaceuticals
11.17.1 ScPharmaceuticals Corporation Information
11.17.2 ScPharmaceuticals Overview
11.17.3 ScPharmaceuticals Wearable Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 ScPharmaceuticals Wearable Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 ScPharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Wearable Drug Delivery Systems Industry Chain Analysis
12.2 Wearable Drug Delivery Systems Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Wearable Drug Delivery Systems Production Mode & Process
12.4 Wearable Drug Delivery Systems Sales and Marketing
12.4.1 Wearable Drug Delivery Systems Sales Channels
12.4.2 Wearable Drug Delivery Systems Distributors
12.5 Wearable Drug Delivery Systems Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Wearable Drug Delivery Systems Industry Trends
13.2 Wearable Drug Delivery Systems Market Drivers
13.3 Wearable Drug Delivery Systems Market Challenges
13.4 Wearable Drug Delivery Systems Market Restraints
14 Key Findings in The Global Wearable Drug Delivery Systems Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のウェアラブルドラッグデリバリーシステム市場インサイト及び予測(電子ドラッグデリバリーデバイス、メカニカルドラッグデリバリーデバイス)(Global Wearable Drug Delivery Systems Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。